Screening And Future Enhanced MRI

SAFE-MRI seeks to enhance breast cancer detection and MRI performance by implementing abbreviated screening for younger women and reducing contrast use through advanced imaging techniques.

Subsidie
€ 2.984.796
2023

Projectdetails

Introduction

SAFE-MRI aims to prevent needless mortality from breast cancer by optimizing the use and performance of dedicated breast MRI.

Objectives

First, SAFE-MRI aims at detecting breast cancer early in women that are currently deemed too young for population screening (age 45-50). Early diagnosis of breast cancer in these women will lead to a large gain in DALYs averted.

Screening Study

I will initiate a prospective screening study inviting women to a one-time only abbreviated breast MRI at the age of 45. The primary outcome will be the cancer detection rate per 1000 women actually screened. This will validate abbreviated breast MRI as a standalone screening technique.

Data Collection

Psycho-social and risk information will be collected from all participants. Cost-effectiveness modeling will be included. A 5-year follow-up will be performed in all women up to, and including, the first screening round at the age of 50.

Improvement of Breast MRI

Second, SAFE-MRI aims at improving breast MRI by reducing the need for contrast administration. This is a major downside of breast MRI for women (IV-cannulation and a small risk of allergic reactions) and the environment (pollution of surface water).

Enhanced Signal Changes

First, I aim to enhance signal changes using a strongly reduced dose of contrast with advanced deep learning (DL).

Unenhanced MRI Studies

Further studies are tailored at the assessment of unenhanced MRI. Particularly, I will validate novel diffusion weighted imaging (DWI) sequences capable of generating high-resolution diagnostic images within short scan times using DL-based reconstruction.

ASL Imaging Strategies

Furthermore, I will investigate arterial spin labeling (ASL) based breast imaging strategies that show perfusion without the need for contrast administration.

Synthetic Breast MRI Images

Finally, we will combine unenhanced MRI techniques in a generative adversarial network to construct synthetic breast MRI images. Repeated reader studies will be conducted to assess image quality and diagnostic value.

Conclusion

SAFE-MRI will thus consolidate my leading role in breast imaging and enable me to design the breast screening of the future.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.984.796
Totale projectbegroting€ 2.984.796

Tijdlijn

Startdatum1-6-2023
Einddatum31-5-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUMpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Revealing liver micrometastases in vivo using ultra-high definition MRI

MicroMetSCAN aims to revolutionize MRI techniques for early detection of liver micrometastases, enhancing cancer diagnosis and treatment through improved imaging sensitivity and biological insights.

€ 1.998.456
ERC Starting...

Transformative Pediatric Brain Cancer Imaging using Integrated Biophysics-AI Molecular MRI

Develop a novel AI-driven molecular MRI technology for rapid, noninvasive monitoring of pediatric brain cancer treatment response, enhancing precision medicine and understanding of tumor dynamics.

€ 1.497.669
ERC Proof of...

Low-dose breast CT with monochromatic x-ray sources

MONOBREAST aims to enhance breast cancer imaging by integrating new monochromatic x-ray sources with advanced reconstruction methods to reduce radiation dose and improve diagnostic accuracy.

€ 150.000
ERC Consolid...

Deuterium labeling of GLUCOse improves magnetic resonance imaging Sensitivity to CANcer metabolism

GLUCO-SCAN aims to develop and clinically evaluate a novel whole-body deuterium metabolic imaging (DMI) method for cancer assessment, overcoming PET's limitations and enabling widespread screening.

€ 2.495.924
ERC Proof of...

MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain research

This project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Transition

Early detection of treatment response in breast cancer

The project aims to enhance breast cancer treatment through Hyperpolarized Magnetic Resonance imaging for early detection of non-responders, improving outcomes and reducing side effects.

€ 2.499.229
EIC Transition

MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care

MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.

€ 2.495.127
EIC Pathfinder

DDG-MRI for cancer detection - A novel medical imaging approach that correlates to FDG-PET without ionising radiation

The DDG-MRI project aims to develop a non-ionizing MRI technique using a novel deuterated glucose analogue to provide PET-like imaging for cancer detection and treatment monitoring.

€ 2.991.061
Mkb-innovati...

BORSTKANKERDETECTIE D.M.V. CAMERATECHNOLOGIEËN/ ARTIFICIËLE INTELLIGENTIE

Sigmascreening onderzoekt de haalbaarheid van een innovatief product voor borstkankerdetectie met 3D-camera's en AI, gericht op toegankelijkheid en marktbehoefte.

€ 20.000
Mkb-innovati...

Haalbaarheidsproject Beter beeld voor een betere diagnose

Het project onderzoekt de toepassing van geavanceerde beeldverwerking in medische technieken om diagnoses te verbeteren en stralingsblootstelling voor patiënten te verminderen.

€ 14.400